Skip to main
BLSM

BLSM Earnings Dates & Reports

BLSM Most Recent Earnings

Report Date
Period EndingQ2 2026
Est. EPS-$0.77
Actual EPS-$8.75
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

BLSM Earnings per Share (EPS) History

Signup for full access
Browse free

BLSM Latest Earnings

The value each BLSM share was expected to gain vs. the value each share gained.

BLSM reported its most recent earnings on for Q2 2026, posting earnings per share (EPS) of -$8.75. This exceeded analysts' expectations of -$0.77 by 1,036.36%, marking a Miss.

For comparison, Blossomhill Therapeutics Inc reported EPS of $0 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.95.

BLSM Earnings History

Earnings
Est. EPSActual EPSSurprise
Q4 2026
-$0.95
Q2 2026
-$0.77-$8.75+1,036.36%

BLSM Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Blossomhill Therapeutics Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

BLSM Earnings FAQs

BLSM last reported earnings on Sep 18, 2026 for Q2 2026, posting an EPS of -$8.75, which Miss the estimate of -$0.77 by 1,036.36%.

For Q2 2026, BLSM reported an EPS of -$8.75, missing analysts' estimate of -$0.77 by 1,036.36%.

For Q2 2026, BLSM Miss expectations with an actual EPS of -$8.75 vs. an estimated EPS of -$0.77.

Following the last earnings report on Sep 18, 2026, BLSM's stock price moved — from — to —.

The next BLSM earnings call is scheduled for Feb. 19, 2027, where executives will discuss financial results and outlook.

Blossomhill Therapeutics Inc (BLSM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.